期刊文献+

临床药师参与一例呼吸衰竭患者并肺部感染及血流感染治疗的病例分析 被引量:4

Case analysis of clinical pharmacists participating in treatment of pulmonary infection and bloodstream infection in one patient with respiratory failure
下载PDF
导出
摘要 目的 探讨临床药师参与危重感染患者药物治疗的实践方式.方法 临床药师在参与1例呼吸衰竭合并感染患者的治疗过程中,对于药物治疗浓度过高进行了系统分析并给予了临床合理建议,参与了患者药物使用方案的调整同时做好了药学监护等方面的工作.结果 临床药师协助临床医生给予患者进行积极救治,并及时做好药学监护,患者感染得到控制.结论 临床药师以专业特长参与临床治疗,可促进合理用药,提高药物治疗水平. Objective To explore the practice methods for clinical pharmacists participating in drug therapy for patients with severe infection. Methods Clinical pharmacists made a systematical analysis of the drugs in the treatment of high concentration and gave the rational advice in the treatment of one patient with respiratory failure and infection. They participated in the patients’ drug use plan adjustment and made pharmaceutical care. Results Clinical pharmacists helped doctors treat the patient actively and promptly and completed the pharmaceutical care. The patient’s infection was under control. Conclusion Clinical pharmacists can promote rational drug use and improve the level of drug treatment with their professional knowledge.
作者 虞燕霞 陈世祺 Yu Yanxia;Chen Shiqi(Department of Pharmacy, Suzhou Hospital, Nanjing Medical University (Suzhou Municipal Hospital), Suzhou 215002, China (Yu YX;Department of Pharmacy, First Hospital, Soochow University, Suzhou 215002, China (Chen SQ)
出处 《国际医药卫生导报》 2018年第10期1563-1565,共3页 International Medicine and Health Guidance News
关键词 临床药师 肺部感染 血流感染 药学监护 Clinical pharmacists Pulmonary infection Bloodstream infection Pharmaceutical care
  • 相关文献

参考文献6

二级参考文献31

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:241
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3065
  • 3王瑶,徐英春.2004—2005年中国CHINET鲍曼不动杆菌耐药性分析[J].中国感染与化疗杂志,2007,7(4):279-282. 被引量:71
  • 4Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients;a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst Pharm,2009;66:82-98.
  • 5Murphy JE,Gillespie DE,Bateman CV.Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters[J].Am J Health Syst Pharm,2006;63:2365-2370.
  • 6Tsuji Y,Hiraki Y,Mizoguchi A,et al.Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods[J].J Clin Pharm Ther,2009;34:465-472.
  • 7Fernández de Gatta Mdel M,Santos Buelga D,Sánchez Navarro A,et al.Vancomycin dosage optimization in patients with malignant haematological disease by pharmacokinetic/ pharmacodynamic analysis[J].Clin Pharmacokinet,2009;48:273-280.
  • 8American Thoracic Society: Infectious Diseases Society of A?merica. Guidelines for the management of adults with hospi?tal-acquired ventilator associated and health care associated pneumonia[J]. Am J Respir Crit Care Med , 2005, 171 (4) : 388-416.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-115,15th informational supplement. Wayne, PA: CLSI. 2005.
  • 10Bassetti M, Repetto E, Righi E, et al. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter bauman?nii infections[J]. J Antimicrob Chemother, 2008, 6t( 2): 417- 420.

共引文献1491

同被引文献40

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部